Drugs / WO3970
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04159610 | Dec 2019 → Oct 2020 | isolated hyperchlorhidrosis | Dr. August Wolff GmbH & Co. KG Arzneimittel | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WO3970 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04159610 ↗ |
| Route | Topical | “Formulation containing WO 3970 for topical application” NCT04159610 ↗ |